William Fry acts for many of the world’s largest pharmaceutical and biotechnology companies, giving us cutting-edge knowledge of the global and national challenges facing companies operating in this highly innovative sector.
We are recognised as Ireland’s leading practice in large scale, multi-jurisdictional litigation in the Pharmaceuticals and Biotechnology sectors. Our team's success lies in its drive to achieve the right commercial outcome for our clients, its strategic expertise and exceptional industry and legal knowledge gained from acting in the majority of patent and SPC cases that have come before the Irish Courts over many years.
We advise on all aspects of the development of pharmaceutical and biotech pharmaceutical products including antibodies, proteins, blood/plasma derived products and recombinant DNA products.
Our Life Sciences team prides itself on working with
- start-ups;
- the world’s largest pharmaceutical and biotechnology companies such as GSK, Boehringer Ingelheim, Eli Lilly, MSD, Genentech and ViiV Healthcare;
- finance providers / venture capital investors; and
- academic institutions.
Our range of services span the entire development cycle of pharmaceutical and biotechnology companies and their products. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (contentious and non-contentious), capital markets and finance, taxation and dispute resolution and every phase of a product's life cycle from product development, clinical trials, regulatory approval to commercialisation, infringement disputes and product safety/recall/liability.